Literature DB >> 23410142

Hypokalemia secondary to bupropion sustained release overdose.

Brent Wilson1, Panchajanya Paul, Sunny Mehta, Barbara J Coffey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23410142      PMCID： PMC3613169          DOI： 10.1089/cap.2013.2313

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  5 in total

1.  Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study.

Authors:  Timothy E Wilens; Barbara R Haight; Joseph P Horrigan; James J Hudziak; Norman E Rosenthal; Daniel F Connor; Kenneth D Hampton; Nathalie E Richard; Jack G Modell
Journal:  Biol Psychiatry       Date:  2005-04-01       Impact factor: 13.382

Review 2.  Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?

Authors:  Hugo R Arias
Journal:  Int J Biochem Cell Biol       Date:  2009-06-02       Impact factor: 5.085

3.  Incidence and onset of delayed seizures after overdoses of extended-release bupropion.

Authors:  Paul Starr; Wendy Klein-Schwartz; Henry Spiller; Perri Kern; Susan E Ekleberry; Susan Kunkel
Journal:  Am J Emerg Med       Date:  2009-10       Impact factor: 2.469

4.  Bupropion overdose: a 3-year multi-center retrospective analysis.

Authors:  H A Spiller; E A Ramoska; E P Krenzelok; S R Sheen; D J Borys; D Villalobos; S Muir; L Jones-Easom
Journal:  Am J Emerg Med       Date:  1994-01       Impact factor: 2.469

5.  Suicidality in pediatric patients treated with antidepressant drugs.

Authors:  Tarek A Hammad; Thomas Laughren; Judith Racoosin
Journal:  Arch Gen Psychiatry       Date:  2006-03
  5 in total
  1 in total

1.  Medication-induced hypokalemia.

Authors:  Keith T Veltri; Carly Mason
Journal:  P T       Date:  2015-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.